Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
ClosePatient Story
Then came the diagnosis. Finding out she had Crohn’s disease, one of two IBD syndromes that affect 10 million people worldwide, wasn’t a surprise considering her family’s history with the disease. But it derailed her life.
What we do, we do
Our Experts
Our Experts
Andreas Reiff, M.D.
Senior Vice President, Global TA Head, Inflammation & Immunology, Global Medical Services
Drawing from 25+ years of experience as a clinician, investigator, and thought leader, Andreas provides strategic, regulatory, and scientific guidance for your projects in inflammation and immunology. He also assists with protocol development and complex market analyses.
"Tina’s story and the many struggles she went through remind us that there are many patients out there who are waiting for us to push the boundaries of research, trying to find new answers to an old disease and its challenges."
Our I&I team is 13,400+ strong, with experience across indications, to match the needs of your trial.
Our diverse project experiences and expertise in patient recruitment and engagement result in fast, efficient trials.
Clinical trial sites around the world allow us to accelerate study startups.
Innovative trial designs allow us to optimize your trials for maximum impact.
And our patient-first approach results in deeper, more relevant insights for trial design and execution.
TACTICS
BENEFITS MAY INCLUDE
What can we do to help you change patient lives?
See I&I capabilities Visit all therapeutic areas Explore I&I careers
Want our latest insights for inflammation and immunology?
Learn moreReady to speak to someone on our team?
Get in touchAre you a patient interested in a clinical trial?
Learn moreThe perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
CloseA dedicated CRO providing the full range of Phase I to IV clinical development services and leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders and sites to design and deliver clinical trials with patients in mind, to make clinical research a care option for anyone, anywhere.